Industry News
Adding IVCF To Fondaparinux Does Not Benefit Cancer Patients With Blood Clots
Jul 08, 2011
Cancer patients with blood clots - which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients - gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented at the 14th World Conference on Lung Cancer, hosted by the Intern... Read More
Lack Of Clarity About HPV Vaccine And The Need For Cervical Cancer Screening
Jul 07, 2011
The research will be presented today [Thursday 7 July] at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol... Read More
Review Of Lung Tumor From A Patient Who Never Smoked Revealed At IASLC Meeting In Amsterdam
Jul 07, 2011
A first-of-its-kind study of a patient with lung cancer who never smoked was presented by TGen and the Virginia G. Piper Cancer Center at Scottsdale Healthcare at the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam. Researchers for the first time sequenced the entire DNA and RNA of a patient with metastatic adenocarcinoma of the lung, said Dr... Read More
UK Lung Cancer Resection Rate Improved By Increased Investment In Thoracic Surgical Expertise
Jul 06, 2011
Increased investment in specialist thoracic surgical expertise can lead to a significant rise in the lung cancer resection rate, based on data from England between 2008 and 2009 that was presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)... Read More
Lung Cancer In Former Smokers May Be Prevented By Celecoxib
Jul 06, 2011
Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to a recent study in Cancer Prevention Research, a journal of the American Association for Cancer Research... Read More
New Treatment Options Between 2003-2009 Improved Survival For Elderly Dutch Lung Cancer Patients'
Jul 06, 2011
New developments such as stereotactic ablative radiotherapy and improvements in surgical care in early-stage lung cancer have led to large survival gains for elderly Dutch patients, according to a population-based study presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)... Read More
Disparities In Lung Cancer Drug Trial Data Submitted To US FDA: Women, Elderly, Minorities Poorly Represented
Jul 06, 2011
Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)... Read More
Using Mouse Model, Researchers Characterize Biomechanics Of Ovarian Cells According To Phenotype At Stages Of Cancer
Jul 06, 2011
Using ovarian surface epithelial cells from mice, researchers from Virginia Tech have released findings from a study that they believe will help in cancer risk assessment, cancer diagnosis, and treatment efficiency in a technical journal: Nanomedicine... Read More
Researchers Characterize Biomechanics Of Ovarian Cells In Mice
Jul 06, 2011
Researchers characterize biomechanics of ovarian cells in mice according to their phenotype at early, intermediate, and late-aggressive stages of cancer Using ovarian surface epithelial cells from mice, researchers from Virginia Tech have released findings from a study that they believe will help in cancer risk assessment, cancer diagnosis, and treatment efficiency in a tech... Read More
News From The Journal Of Clinical Investigation: July 1, 2011
Jul 03, 2011
ONCOLOGY: Role for stem cells in tumor development Ovarian cancer is the fifth most common cancer among women. New research, performed by Ronald Buckanovich and colleagues, at the University of Michigan Medical Center, Ann Arbor, provides insight into the cellular and molecular mechanisms that promote ovarian tumor development and thereby identifies a potential new therapeutic approach... Read More
Previous Page Next Page